EL
Insider
Emily M. Leproust
Chief Executive OfficerEmily M. Leproust (Chief Executive Officer) filed 20 Form 4 reports in the trailing twelve months (0 purchases, 20 sales), most often in Twist Bioscience Corporation (TWST). The largest single filing was $56.3M of TWST (356,546 sh across 13 lots, as filed), executed Sep 17.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
20
0 buys · 20 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$91.0M
shares × price, as filed
Last traded
Sep 17
Filed yesterday
Median ADV $206.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $94.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
20 filings
Sector per market data · by filing · past 12 months
Most traded names
TWSTRecent filings
TWSTSALE
Twist Bioscience Corporation
View filing →
$117K2,216 sh × $52.70
Exec Dec 6 2024
Filed Dec 10 2024 · 5:30 PM ET TWSTSALE Twist Bioscience Corporation View filing → $382K
7,968 sh × $48.00
Exec Nov 11 2024
Filed Nov 13 2024 · 5:30 PM ET TWSTSALE Twist Bioscience Corporation View filing → $639K
14,334 sh × $44.61
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET TWSTSALE Twist Bioscience Corporation View filing → $639K
14,334 sh × $44.61
Exec Nov 6 2024
Filed Nov 15 2024 · 5:30 PM ET †